KPW
BIIB icon

Kore Private Wealth’s Biogen BIIB Stock Holding History

Kore Private Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-134
Closed -$35K – 363
2020
Q2 		$35K Sell
134
-14
-9% -$4.21K 0.01% 534
2020
Q1 		$47K Buy
148
+38
+35% +$11.5K 0.01% 425
2019
Q4 		$33K Buy
+110
New +$30.5K 0.01% 538
2019
Q2 		– Sell
-109
Closed -$26K – 293
2019
Q1 		$26K Hold
109
– – 0.01% 475
2018
Q4 		$33K Buy
+109
New +$34.8K 0.01% 430

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Kore Private Wealth's BIIB Position: Q3 2020 in Review

Kore Private Wealth sold out of Biogen (BIIB) in Q3 2020, closing a stake of 134 shares — an estimated $35K sold.

Kore Private Wealth first reported a position in BIIB in Q4 2018 and held it in 5 quarters. The position peaked at $47K in Q1 2020. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

  • Kore Private Wealth reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
  • Kore Private Wealth sold 134 Biogen shares in Q3 2020, an estimated $35K.
  • Kore Private Wealth first reported a position in Biogen in Q4 2018 and held it in 5 quarters.
  • Kore Private Wealth's Biogen position peaked at $47K in Q1 2020.
  • 1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Kore Private Wealth's 13F filing for Q3 2020, filed 13 Nov 2020.